| Depression as a microglial disease R Yirmiya, N Rimmerman, R Reshef Trends in neurosciences 38 (10), 637-658, 2015 | 757 | 2015 |
| N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor D McHugh, SSJ Hu, N Rimmerman, A Juknat, Z Vogel, JM Walker, ... BMC neuroscience 11, 1-14, 2010 | 342 | 2010 |
| Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-κB and interferon-β/STAT proinflammatory pathways in BV-2 … E Kozela, M Pietr, A Juknat, N Rimmerman, R Levy, Z Vogel Journal of biological chemistry 285 (3), 1616-1626, 2010 | 301 | 2010 |
| Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain A Moussaieff, N Rimmerman, T Bregman, A Straiker, CC Felder, ... The FASEB Journal 22 (8), 3024, 2008 | 237 | 2008 |
| Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators HB Bradshaw, N Rimmerman, JF Krey, JM Walker American Journal of Physiology-Regulatory, Integrative and Comparative …, 2006 | 227 | 2006 |
| Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice E Kozela, N Lev, N Kaushansky, R Eilam, N Rimmerman, R Levy, ... British journal of pharmacology 163 (7), 1507-1519, 2011 | 214 | 2011 |
| Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death N Rimmerman, D Ben-Hail, Z Porat, A Juknat, E Kozela, MP Daniels, ... Cell death & disease 4 (12), e949-e949, 2013 | 168 | 2013 |
| Differential changes in GPR55 during microglial cell activation M Pietr, E Kozela, R Levy, N Rimmerman, YH Lin, N Stella, Z Vogel, ... FEBS letters 583 (12), 2071-2076, 2009 | 154 | 2009 |
| The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways HB Bradshaw, N Rimmerman, SSJ Hu, VM Benton, JM Stuart, K Masuda, ... BMC biochemistry 10, 1-11, 2009 | 146 | 2009 |
| Cannabinoids decrease the th17 inflammatory autoimmune phenotype E Kozela, A Juknat, N Kaushansky, N Rimmerman, A Ben-Nun, Z Vogel Journal of Neuroimmune Pharmacology 8, 1265-1276, 2013 | 137 | 2013 |
| Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells A Juknat, M Pietr, E Kozela, N Rimmerman, R Levy, F Gao, G Coppola, ... PloS one 8 (4), e61462, 2013 | 126 | 2013 |
| Novel endogenous N‐acyl glycines: identification and characterization HB Bradshaw, N Rimmerman, SSJ Hu, S Burstein, JM Walker Vitamins & Hormones 81, 191-205, 2009 | 107 | 2009 |
| N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons N Rimmerman, HB Bradshaw, JSC Chen, SSJ Hu, D McHugh, E Vefring, ... Molecular pharmacology 74 (1), 213-224, 2008 | 97 | 2008 |
| The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb R Reshef, E Kudryavitskaya, H Shani-Narkiss, B Isaacson, N Rimmerman, ... Elife 6, e30809, 2017 | 94 | 2017 |
| Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells A Juknat, M Pietr, E Kozela, N Rimmerman, R Levy, G Coppola, ... British journal of pharmacology 165 (8), 2512-2528, 2012 | 93 | 2012 |
| Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line N Rimmerman, HV Hughes, HB Bradshaw, MX Pazos, K Mackie, ... British journal of pharmacology 153 (2), 380-389, 2008 | 86 | 2008 |
| Targeted lipidomics: discovery of new fatty acyl amides B Tan, HB Bradshaw, N Rimmerman, H Srinivasan, YW Yu, JF Krey, ... The AAPS journal 8, E461-E465, 2006 | 66 | 2006 |
| The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency N Rimmerman, N Schottlender, R Reshef, N Dan-Goor, R Yirmiya Brain, behavior, and immunity 61, 184-196, 2017 | 59 | 2017 |
| Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells CA Opitz, N Rimmerman, Y Zhang, LE Mead, MC Yoder, DA Ingram, ... FEBS letters 581 (25), 4927-4931, 2007 | 42 | 2007 |
| Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin‐1 N Rimmerman, HB Bradshaw, E Kozela, R Levy, A Juknat, Z Vogel British journal of pharmacology 165 (8), 2436-2449, 2012 | 38 | 2012 |
Vogel ZviProf. of BiochemistryVerified email at weizmann.ac.il
